Cargando…

Profile of the Nicotinic Cholinergic Receptor Alpha 7 Subunit Gene Expression is Associated with Response to Varenicline Treatment

Introduction: Smoking is considered the leading cause of preventable morbidity and mortality worldwide. Studies have sought to identify predictors of response to smoking cessation treatments. The aim of this study was to analyze a possible association of target gene expression for smoking cessation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Santos, Juliana Rocha, Tomaz, Paulo Roberto Xavier, Scholz, Jaqueline Ribeiro, Gaya, Patrícia Viviane, Abe, Tânia Ogawa, Krieger, José Eduardo, Pereira, Alexandre Costa, Santos, Paulo Caleb Júnior de Lima
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7397196/ https://www.ncbi.nlm.nih.gov/pubmed/32640505 http://dx.doi.org/10.3390/genes11070746

Ejemplares similares

Cholinergic receptor nicotinic alpha 5 subunit polymorphisms are associated with smoking cessation success in women
por: Tomaz, Paulo Roberto Xavier, et al.
Publicado: (2018)

Evaluation of the nicotine metabolite ratio in smoking patients treated with varenicline and bupropion
por: Tomaz, Paulo Roberto Xavier, et al.
Publicado: (2022)

Cue restricted smoking increases quit rates with varenicline
por: Scholz, Jaqueline R., et al.
Publicado: (2021)

CHRNA4 rs1044396 is associated with smoking cessation in varenicline therapy
por: Rocha Santos, Juliana, et al.
Publicado: (2015)

Influence of smoking cessation drugs on blood pressure and heart rate in patients with cardiovascular disease or high risk score: real life setting
por: Silva, André Pacheco, et al.
Publicado: (2016)

Effects of aging on the effectiveness of smoking cessation medication
por: Scholz, Jaqueline, et al.
Publicado: (2016)

The SARS-CoV-2 Virus and the Cholinergic System: Spike Protein Interaction with Human Nicotinic Acetylcholine Receptors and the Nicotinic Agonist Varenicline
por: Carlson, Eric C., et al.
Publicado: (2023)

Could APO-varenicline and cytisine be solutions for the shortage of varenicline in Brazil?
por: Corrêa, Paulo César Rodrigues Pinto, et al.
Publicado: (2023)

Varenicline for Smoking Cessation: Nausea Severity and Variation in Nicotinic Receptor Genes
por: Swan, Gary E., et al.
Publicado: (2011)

Combination of varenicline and nicotine patch for smoking cessation: A case report
por: Young, Kelly M., et al.
Publicado: (2019)

Combination of behavioral therapy and varenicline for smoking cessation: Time to beat nicotine
por: Agarwal, Avnica, et al.
Publicado: (2022)

Overexpression of cholinergic receptor nicotinic gamma subunit inhibits proliferation and differentiation of bovine preadipocytes
por: Du, Jiawei, et al.
Publicado: (2023)

Is a combination of varenicline and nicotine patch more effective in helping smokers quit than varenicline alone? A randomised controlled trial
por: Hajek, Peter, et al.
Publicado: (2013)

Neurocircuitry of the nicotinic cholinergic system
por: Bertrand, Daniel
Publicado: (2010)

Combination therapy of varenicline with nicotine replacement therapy is better than varenicline alone: a systematic review and meta-analysis of randomized controlled trials
por: Chang, Ping-Hsun, et al.
Publicado: (2015)

A Case Report on Varenicline Induced Delirium in an Alcohol and Nicotine Dependent Patient
por: Narayan, A. Lakshmi, et al.
Publicado: (2015)

2532: Predictive metabolism studies of varenicline and implications of its metabolites in nicotine addiction
por: Thompson, Keeshaloy, et al.
Publicado: (2018)

EDITORIAL: Nicotine and the Nicotinic Cholinergic System in Health and Disease
por: Pogun, Sakire
Publicado: (2018)

Varenicline enhances dopamine release facilitation more than nicotine after long-term nicotine treatment and withdrawal
por: Perez, Xiomara A, et al.
Publicado: (2015)

Varenicline Targets the Reinforcing-Enhancing Effect of Nicotine on Its Associated Salient Cue During Nicotine Self-administration in the Rat
por: Garcia-Rivas, Vernon, et al.
Publicado: (2019)

Combining varenicline and nicotine patches: a randomized controlled trial study in smoking cessation
por: Ramon, Josep M, et al.
Publicado: (2014)

Artemin growth factor increases nicotinic cholinergic receptor subunit expression and activity in nociceptive sensory neurons
por: Albers, Kathryn M, et al.
Publicado: (2014)

Replicated Risk Nicotinic Cholinergic Receptor Genes for Nicotine Dependence
por: Zuo, Lingjun, et al.
Publicado: (2016)

COVID-19 and the nicotinic cholinergic system
por: Farsalinos, Konstantinos, et al.
Publicado: (2020)

Cholinergic receptor, nicotinic, alpha 7 as a target molecule of Arctic mutant amyloid β
por: Sawamura, Naoya, et al.
Publicado: (2018)

Flexible, dual-form nicotine replacement therapy or varenicline in comparison with nicotine patch for smoking cessation: a randomized controlled trial
por: Tulloch, Heather E., et al.
Publicado: (2016)

Varenicline and Nicotine Replacement Use Associated With US Food and Drug Administration Drug Safety Communications
por: Desai, Ravi J., et al.
Publicado: (2019)

Adaptive Smoking Cessation Using Precessation Varenicline or Nicotine Patch: A Randomized Clinical Trial
por: Davis, James M., et al.
Publicado: (2023)

Dopaminergic and cholinergic learning mechanisms in nicotine addiction
por: Subramaniyan, Manivannan, et al.
Publicado: (2015)

The role of nicotinic cholinergic neurotransmission in delusional thinking
por: Caton, Michael, et al.
Publicado: (2020)

Compromised neuroplasticity in cigarette smokers under nicotine withdrawal is restituted by the nicotinic α(4)β(2)-receptor partial agonist varenicline
por: Batsikadze, G., et al.
Publicado: (2017)

Varenicline attenuates cue-induced relapse to alcohol, but not nicotine seeking, while reducing inhibitory response control
por: Wouda, Jelte A., et al.
Publicado: (2011)

Prospective cohort study of the effectiveness of varenicline versus nicotine replacement therapy for smoking cessation in the “real world”
por: Kotz, Daniel, et al.
Publicado: (2014)

PET Imaging of the Human Nicotinic Cholinergic Pathway in Atherosclerosis
por: Bauwens, Matthias, et al.
Publicado: (2015)

Varenicline versus transdermal nicotine patch for smoking cessation: results from a randomised open-label trial
por: Aubin, H-J, et al.
Publicado: (2008)

Varenicline decreases ethanol intake and increases dopamine release via neuronal nicotinic acetylcholine receptors in the nucleus accumbens
por: Feduccia, A A, et al.
Publicado: (2014)

Using cost-effectiveness analysis to support policy change: varenicline and nicotine replacement therapy for smoking cessation in Jordan
por: Madae’en, Saba, et al.
Publicado: (2020)

Varenicline Prevents LPS-Induced Inflammatory Response via Nicotinic Acetylcholine Receptors in RAW 264.7 Macrophages
por: Baris, Elif, et al.
Publicado: (2021)

Varenicline in the treatment of tobacco dependence
por: Fagerström, Karl, et al.
Publicado: (2008)

Smoking cessation therapy with varenicline
por: Mohanasundaram, Uma M, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_e04eubpsbj1curgmihjpsjkuec